SR One Capital Management — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
ARS PharmaceuticalsNASDAQ: SPRYSep 2021SEC filingmedium confidence
BiotechSan Diego, US
Jonathan Leff(Director)Richard Lowenthal(Executive Officer, Director)Pratik Shah(Director)
Board seatRajeev Dadoo· per SEC Form D · $55M raise · filed Sep 2021
Regulus Therapeutics Inc.Dec 2021SEC filingmedium confidence
San Diego, US
Board seatJake Nunn· per SEC Form D · $34.6M raise · filed Dec 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.